neurology

News

Sanofi hands back neurology gene therapy rights to Voyager

Sanofi’s Genzyme unit has handed back rights to two neurology gene therapies to US biotech Voyager Therapeutics, as part of a rethink of the companies’ joint research.

News

Closeup of X-ray photography of human brain

Bayer's regorafenib kicks off brain cancer platform trial

Bayer has become the first pharma company to take part in a new platform trial designed to find new treatments for brain cancer.

News

Scientists recreate blood-brain barrier on a chip

Scientists in Israel and the US have duplicated the blood-brain barrier in a chip using human stem cells, which can be used to develop personalised medicine and inform research into brain d

News

Janssen J&J Johnson and Johnson pharmaceutical companies

J&J unveils top pipeline prospects, with main focus on cance...

Johnson & Johnson has shone the spotlight on the most promising drugs in its pipeline, saying it plans to file 10 major drugs between now and 2023.

News

German Merck shows new data backing BTK drug evobrutinib in ...

Germany’s Merck KGaA has announced new mid-stage data that it says support further studies into its BTK inhibitor drug evobrutinib in multiple sclerosis, which could provide patients with a

News

NICE backs Ocrevus for PPMS in England - but with caveats

Patients with a severe progressive form of multiple sclerosis will get access to the first licensed treatment for the condition after NICE recommended regular NHS funding for Roche's Ocrevu

Sanofi hands back neurology gene therapy rights to Voyager

Bayer's regorafenib kicks off brain cancer platform trial

Scientists recreate blood-brain barrier on a chip

J&J unveils top pipeline prospects, with main focus on cance...

German Merck shows new data backing BTK drug evobrutinib in ...

NICE backs Ocrevus for PPMS in England - but with caveats

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

neurology

Editor's Picks